TECHNOLOGY TRANSFER

Innovator Profile

Headshot of Steve Dow.

Steve Dow, DVM, PhD

Professor, Department of Microbiology, Immunology, and Pathology

Primary College

Innovator Links

Innovator Bio

The two main areas of research interest are immunotherapy for cancer and ocular diseases and cell-based therapy for treating chronic infections.

Everything we do is with an eye to translational research. We do studies on animals, but we always have an eye to where the human market is. The best-case scenario is where we win at both and create a veterinary product and a human product.

CSU-Affiliated Startups

Innovator Patents

US20200069795A1: Compositions and methods for enhancing innate immunity in a subject for treatment of infections and cancer and other acute and chronic conditions of the eye.

WO2020028007A1: Compositions, methods and uses for modulating the tumor microenvironment to enhance antitumor immunity.

US10512687B2: Compositions and methods for enhanced innate immunity.

US10206983B2: Methods and compositions for enhancing an immune response, blocking monocyte migration, amplifying vaccine immunity and inhibiting tumor growth and metastasis.

WO2017100328A1: Activated stem cells and systemic treatment methods for infected wounds.

WO2016161309A1: Optimized cancer stem cell vaccines.

US20160287686A1: Myeloid derived suppressor cell inhibiting agents.

WO2014134621A3: Methods and compositions for enhancing an immune response, blocking monocyte migration, amplifying vaccine immunity and inhibiting tumor growth and metastasis.

US20110002980A1: Vaccines using nucleic acid-lipid complexes.*

US20090169612A1,WO1999066879A3: Systemic Immune Activation Method Using Nucleic Acid-Lipid Complexes.

WO2008057696A2: Compositions of pattern recognition receptor-ligand: lipid complexes and methods of use thereof.

WO2005079511A2: SYSTEM IMMUNE ACTIVATION METHOD USING NON CpG NUCLEIC ACIDS.*

WO2005013891A3: Vaccines using pattern recognition receptor-ligand:lipid complexes.*

*Assignee other than CSU STRATA.

Patent list generated using Google Patents.